Tag: Vaccine
Bharat Biotech’s Zika vaccine animal trials show 100% efficacy
Out of the two vaccine candidates including an inactivated and a recombinant vaccine, against zika virus announced by the company in 2016, the former has shown promising results..........
A step closer to a simpler & affordable oral cholera vaccine
After the successful toxicology studies, the promising Cholera vaccine “HILLCHOLTM is currently undergoing human clinical trial Phase I/II in collaboration with ICDDR, B and Incepta Vaccine Ltd in Bangladesh..........
PATH welcomes new promising study results for rotavirus vaccine candidate
PATH is also working with Serum Institute to conduct an additional Phase 3 study to gather data required for World Health Organization (WHO) prequalification
Hilleman Lab partners with NICED, ICMR to develop Shigella vaccine
The Hilleman Laboratories on March 29, 2017 signed a memorandum of understanding (MoU) with NICED, ICMR to develop an indigenous Shigella vaccine.....
Celebrating India’s role as the vaccine hub of the world
The Serum Institute, PATH, WHO and Bill & Melinda Gates Foundation with support from the Department of Biotechnology celebrated the clinical development, manufacturing and scale-up of MenAfriVac vaccine......
Serum Institute, Cipla launch Hepatitis B vaccine in India
Under a co-exclusive agreement with Serum Institute of India (SII), global pharmaceutical company Cipla has launched adult Hepatitis B vaccine in India.....
BioVoice eMag February 2017 Issue-9 Volume-1
BioVoice eMag February 2017 Issue-9 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...
Universal Immunization: Health ministry launches single vaccine against measles & rubella
Following the campaign, Measles-Rubella vaccine will be introduced in routine immunization, replacing the currently given two doses of measles vaccine....
Immunotherapy to tackle cancer, India tests first dendritic cell vaccine
Cancer antigen SPAG9 discovered at National Institute of Immunology after being tested successfully in the first phase of clinical trials, is now undergoing second phase of trials involving longer and detailed study.......
Catalent Biologics collaborates with PATH Malaria Vaccine Initiative
The joint partnership aims to create antibodies for malaria vaccine research and development approach using Catalent GPEx cell line technology.....